S'abonner

Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study - 23/02/18

Doi : 10.1016/S1473-3099(17)30727-2 
Thalia Velho Barreto de Araújo, PhD a, ⁎ , Ricardo Arraes de Alencar Ximenes, ProfPhD b, c, Demócrito de Barros Miranda-Filho, PhD c, Wayner Vieira Souza, PhD d, Ulisses Ramos Montarroyos, PhD c, Ana Paula Lopes de Melo, MSc e, Sandra Valongueiro, PhD a, Maria de Fátima Pessoa Militão de Albuquerque, PhD d, Cynthia Braga, PhD d, Sinval Pinto Brandão Filho, PhD d, Marli Tenório Cordeiro, PhD d, Enrique Vazquez, PhD f, Danielle di Cavalcanti Souza Cruz, MD g, Claudio Maierovitch Pessanha Henriques, MSc h, Luciana Caroline Albuquerque Bezerra, MSc i, Priscila Mayrelle da Silva Castanha, PhD d, Rafael Dhalia, PhD d, Ernesto Torres Azevedo Marques-Júnior, PhD d, j, Celina Maria Turchi Martelli, ProfPhD d, *, Laura Cunha Rodrigues, ProfPhD k, *
on behalf of

investigators from the Microcephaly Epidemic Research Group

Carmen Dhalia, Marcela Santos, Fanny Cortes

the Brazilian Ministry of Health

Wanderson Kleber de Oliveira, Giovanini Evelim Coelho

the Pan American Health Organization

Juan Jose Cortez-Escalante, Carlos Frederico Campelo de Albuquerque de Melo, Pilar Ramon-Pardo, Sylvain Aldighieri, Jairo Mendez-Rico, Marcos Espinal

Instituto de Medicina Integral Professor Fernando Figueira

Leuridan Torres, Adriano Nassri Hazin, Ana Van der Linden, Monica Coentro

the State Health Department of Pernambuco†

  Investigators contributing on behalf of these organisations are listed in the Supplementary Material
George Santiago Dimech, Romildo Siqueira de Assuncao, Patricia Ismael de Carvalho, Valdete Felix Oliveira

a Department of Social Medicine, Federal University of Pernambuco, Recife, Brazil 
b Department of Tropical Medicine, Federal University of Pernambuco, Recife, Brazil 
c University of Pernambuco, Recife, Brazil 
d The Research Centre Aggeu Magalhães (CPqAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Brazil 
e Department of Community Health, Federal University of Pernambuco, Vitória de Santo Antão, Brazil 
f Pan American Health Organization, Brasília, Brazil 
g Instituto Materno Infantil Fernando Figueira, Recife, Brazil 
h Brazilian Ministry of Health, Brasília, Brazil 
i State Health Department of Pernambuco, Recife, Brazil 
j Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA 
k Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK 

* Correspondence to: Dr Thália Velho Barreto de Araújo, Federal University of Pernambuco, Recife, Pernambuco 50.670-901, Brazil Correspondence to: Dr Thália Velho Barreto de Araújo, Federal University of Pernambuco Pernambuco 50.670-901 Recife Brazil

Summary

Background

A Zika virus epidemic emerged in northeast Brazil in 2015 and was followed by a striking increase in congenital microcephaly cases, triggering a declaration of an international public health emergency. This is the final report of the first case-control study evaluating the potential causes of microcephaly: congenital Zika virus infection, vaccines, and larvicides. The published preliminary report suggested a strong association between microcephaly and congenital Zika virus infection.

Methods

We did a case-control study in eight public maternity hospitals in Recife, Brazil. Cases were neonates born with microcephaly, defined as a head circumference of 2 SD below the mean. Two controls without microcephaly were matched to each case by expected date of delivery and area of residence. We tested the serum of cases and controls and the CSF of cases for detection of Zika virus genomes with quantitative RT-PCR and for detection of IgM antibodies with capture-IgM ELISA. We also tested maternal serum with plaque reduction neutralisation assays for Zika and dengue viruses. We estimated matched crude and adjusted odds ratios with exact conditional logistic regression to determine the association between microcephaly and Zika virus infection.

Findings

We screened neonates born between Jan 15 and Nov 30, 2016, and prospectively recruited 91 cases and 173 controls. In 32 (35%) cases, congenital Zika virus infection was confirmed by laboratory tests and no controls had confirmed Zika virus infections. 69 (83%) of 83 cases with known birthweight were small for gestational age, compared with eight (5%) of 173 controls. The overall matched odds ratio was 73·1 (95% CI 13·0–∞) for microcephaly and Zika virus infection after adjustments. Neither vaccination during pregnancy or use of the larvicide pyriproxyfen was associated with microcephaly. Results of laboratory tests for Zika virus and brain imaging results were available for 79 (87%) cases; within these cases, ten were positive for Zika virus and had cerebral abnormalities, 13 were positive for Zika infection but had no cerebral abnormalities, and 11 were negative for Zika virus but had cerebral abnormalities.

Interpretation

The association between microcephaly and congenital Zika virus infection was confirmed. We provide evidence of the absence of an effect of other potential factors, such as exposure to pyriproxyfen or vaccines (tetanus, diphtheria, and acellular pertussis, measles and rubella, or measles, mumps, and rubella) during pregnancy, confirming the findings of an ecological study of pyriproxyfen in Pernambuco and previous studies on the safety of Tdap vaccine administration during pregnancy.

Funding

Brazilian Ministry of Health, Pan American Health Organization, and Enhancing Research Activity in Epidemic Situations.

Le texte complet de cet article est disponible en PDF.

Plan


© 2018  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 18 - N° 3

P. 328-336 - mars 2018 Retour au numéro
Article précédent Article précédent
  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
  • Evelina Tacconelli, Elena Carrara, Alessia Savoldi, Stephan Harbarth, Marc Mendelson, Dominique L Monnet, Céline Pulcini, Gunnar Kahlmeter, Jan Kluytmans, Yehuda Carmeli, Marc Ouellette, Kevin Outterson, Jean Patel, Marco Cavaleri, Edward M Cox, Chris R Houchens, M Lindsay Grayson, Paul Hansen, Nalini Singh, Ursula Theuretzbacher, Nicola Magrini, WHO Pathogens Priority List Working Group, Aaron Oladipo Aboderin, Seif Salem Al-Abri, Nordiah Awang Jalil, Nur Benzonana, Sanjay Bhattacharya, Adrian John Brink, Francesco Robert Burkert, Otto Cars, Giuseppe Cornaglia, Oliver James Dyar, Alex W Friedrich, Ana C Gales, Sumanth Gandra, Christian Georg Giske, Debra A Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzman Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy Jinks, Souha S Kanj, Lawrence Kerr, Marie-Paule Kieny, Yang Soo Kim, Roman S Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Gabriel Levy-Hara, Jasper Littman, Surbhi Malhotra-Kumar, Vikas Manchanda, Lorenzo Moja, Babacar Ndoye, Angelo Pan, David L Paterson, Mical Paul, Haibo Qiu, Pilar Ramon-Pardo, Jesús Rodríguez-Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy E Thwaites, Jos WM van der Meer, Nguyen Van Kinh, Silvio Vega, Maria Virginia Villegas, Agnes Wechsler-Fördös, Heiman Frank Louis Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet
| Article suivant Article suivant
  • Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
  • Roberto Amato, Richard D Pearson, Jacob Almagro-Garcia, Chanaki Amaratunga, Pharath Lim, Seila Suon, Sokunthea Sreng, Eleanor Drury, Jim Stalker, Olivo Miotto, Rick M Fairhurst, Dominic P Kwiatkowski

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.